Wordt geladen...
Role of oral teriflunomide in the management of multiple sclerosis
The landscape of the treatment of relapsing–remitting multiple sclerosis is changing fast. Several oral treatments have shown benefit and generate much interest because of the convenience of their administration. Two oral compounds, fingolimod and teriflunomide, have been approved in relapsing–remit...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3639219/ https://ncbi.nlm.nih.gov/pubmed/23637535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S31248 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|